genotyp
human
papillomaviru
hpv
main
reason
cervic
cancer
common
sexual
transmit
virus
world
bruggmann
et
al
base
annual
report
intern
agenc
research
cancer
evalu
iarc
twelv
type
hpv
ie
classifi
highrisk
type
among
highrisk
hpv
type
hpv
highest
preval
among
women
cervic
cancer
world
bruggmann
et
al
hpv
genom
kb
circular
doubl
strand
dna
encod
eight
open
read
frame
orf
consist
earli
late
gene
earli
protein
play
vital
role
cell
cycl
signal
pathway
genom
replic
transcript
contrast
late
protein
involv
capsid
format
liu
et
al
graham
nowaday
three
commerci
hpv
prophylact
vaccin
avail
none
show
therapeut
effect
exist
hpv
infect
relat
cancer
bharadwaj
et
al
joura
et
al
thu
due
high
preval
hpv
infect
develop
effect
therapeut
vaccin
indispens
moreov
hpv
protein
ideal
target
gener
therapeut
vaccin
due
import
role
tumor
pathogenesi
cellular
transform
degrad
prb
viru
replic
hoppeseyl
et
al
ganguli
sever
therapeut
vaccin
develop
base
viral
oncoprotein
ideal
target
includ
live
vectorbas
vaccin
bacteri
viral
vectorsbas
vaccin
dna
rna
vectorsbas
vaccin
peptid
proteinbas
vaccin
whole
cellbas
vaccin
howev
strategi
show
advantag
disadvantag
yang
et
al
thu
import
find
effect
safe
method
therapeut
vaccin
design
eg
increas
immunogen
gomezgutierrez
et
al
cassetti
et
al
reini
et
al
among
differ
approach
peptid
vaccin
known
key
strategi
variou
advantag
high
select
sensit
easi
product
costeffect
valuabl
peptid
vaccin
compos
immunodomin
bcell
epitop
reduc
immun
respons
selfantigen
ie
autoimmun
therefor
main
step
interact
epitop
major
histocompat
complex
mhc
li
et
al
bioinformat
tool
develop
differ
aspect
immunolog
featur
epitop
predict
map
molecular
model
structur
vaccinolog
sirskyj
et
al
tool
predict
highli
immunogen
epitop
short
time
high
specif
use
develop
effect
vaccin
jurtz
et
al
studi
design
novel
therapeut
vaccin
major
high
risk
hpv
type
use
sequencebas
structur
vaccinolog
immunoinformat
tool
protein
hpv
consid
design
peptid
construct
prepar
construct
use
bioinformat
analysi
potenc
assess
vivo
studi
ie
induct
immun
respons
tumor
erad
mice
base
previou
studi
panahi
et
al
eight
epitop
protein
select
accord
bioinformat
analysi
epitop
highest
score
import
paramet
bind
affin
peptid
mhc
mhci
process
peptidemhc
dock
popul
coverag
physicochem
properti
design
construct
molecular
weight
theoret
pi
neg
posit
charg
residu
estim
halftim
instabl
index
solvent
access
determin
protparam
http
webexpasyorgprotparam
tool
predictprotein
http
wwwpredictproteinorg
scratch
server
http
scratchproteomicsicsuciedu
determin
abil
select
epitop
induc
interferongamma
ifnepitop
server
http
crddosddnetraghavaifnepitopepredictphp
use
studi
use
motif
svm
hybrid
algorithm
accuraci
ifngamma
versu
non
ifngamma
model
predict
dhanda
et
al
protein
signific
role
induc
allergen
reaction
thu
potenti
allergen
determin
especi
vaccin
develop
allergen
select
epitop
calcul
server
http
use
afdsmotif
allergen
onlin
wordmatch
algorithm
specif
method
afd
chrysostom
seker
structur
design
construct
gener
itass
server
http
zhanglabccmbmedumicheduitass
base
experi
itass
server
rank
server
predict
structur
protein
itass
server
use
hierarch
approach
predict
protein
structur
includ
identif
structur
templat
pdb
lomet
b
fragment
assembl
c
model
select
function
annot
yang
et
al
top
structur
model
obtain
itass
refin
galaxyrefin
server
http
perform
iter
optim
sever
geometr
oper
increas
accuraci
initi
model
method
util
global
oper
eg
anisotrop
normal
mode
perturb
secondari
structur
perturb
local
oper
eg
loop
model
hybrid
well
local
error
estim
homolog
structur
inform
lee
et
al
valid
select
best
model
refin
structur
model
obtain
server
analyz
save
server
http
servicesnmbiuclaedusav
save
server
use
five
differ
algorithm
errat
prove
procheck
ramachandran
plot
whatcheck
valid
check
stereochem
qualiti
atom
interact
predict
structur
predict
linear
discontinu
antibodi
epitop
refin
model
analyz
ellipro
server
http
toolsiedborgelliprohelp
ellipro
server
use
modifi
thornton
method
along
residu
cluster
algorithm
epitop
predict
paramet
minimum
score
maximum
distanc
set
default
valu
ponomarenko
et
al
evalu
immun
two
peptid
construct
fig
synthes
biomatik
corpor
canada
puriti
synthes
peptid
prepar
salt
form
acet
salt
cold
chain
situat
accord
compani
instruct
peptid
receiv
lyophil
form
dissolv
water
mgml
store
inbr
femal
mice
week
old
obtain
breed
stock
maintain
pasteur
institut
iran
mice
maintain
specif
pathogenfre
condit
procedur
perform
accord
approv
protocol
pasteur
institut
iran
nation
guidelin
scientif
purpos
five
group
six
mice
select
mice
immun
day
peptid
construct
peptid
peptid
phosphatebuff
salin
sigma
peptid
emulsifi
montanid
gsk
compani
ratio
vv
oil
aqueou
phase
montanid
isa
made
natur
metaboliz
nonminer
oil
highli
refin
emulsifi
mannid
monool
famili
rapidli
metabol
elimin
aucouturi
et
al
inbr
femal
mice
subcutan
inject
right
footpad
differ
regimen
three
time
interv
indic
tabl
week
last
immun
mice
subcutan
challeng
right
flank
tumor
cell
monitor
tumor
growth
percentag
tumorfre
mice
ie
surviv
rate
palpat
twice
week
time
point
tumor
size
determin
measur
smallest
diamet
biggest
diamet
b
calip
tumor
volum
calcul
use
formula
v
li
et
al
cancer
cell
line
atcc
number
deriv
primari
lung
epitheli
cell
mice
cotransform
ra
oncogen
ji
et
al
cell
cultur
rpmi
sigma
germani
supplement
heatinactiv
fetal
bovin
serum
fb
sigma
germani
mm
lglutamin
sigma
germani
gentamicin
sigma
germani
incub
day
tumor
challeng
cell
harvest
trypsin
wash
count
final
resuspend
schemat
model
immun
program
shown
supplementari
mice
prophylact
studi
bled
retroorbit
anesthesia
use
intraperiton
inject
ketamin
mgkg
xylazin
mgkg
cocktail
g
mous
week
second
booster
sera
pool
group
use
indirect
elisa
detect
product
antibodi
peptid
briefli
flatbottom
elisa
plate
greiner
germani
coat
overnight
antigen
ie
peptid
peptid
peptid
dilut
ph
sigma
germani
plate
rins
wash
buffer
vv
incub
block
buffer
bsa
sigma
germani
h
pool
sera
dilut
dilut
buffer
vv
block
buffer
ad
plate
incub
h
rins
wash
buffer
plate
incub
horseradish
peroxidaseconjug
goat
antimous
total
igg
antibodi
dilut
bsapbstween
sigma
germani
h
detect
done
tmb
sigma
germani
substrat
follow
incub
min
room
temperatur
enzym
reaction
stop
merck
germani
absorb
measur
nm
three
mice
group
prophylact
studi
sacrif
randomli
anesthesia
challeng
spleen
remov
homogen
red
blood
celldeplet
pool
splenocyt
cellsml
cultur
plate
nunc
germani
contain
rpmi
medium
supplement
heatinactiv
fb
h
presenc
peptid
peptid
peptid
concanavalin
cona
posit
control
supernat
harvest
gener
cytokin
measur
sandwichbas
elisa
method
use
maptek
elisa
kit
accord
manufactur
instruct
data
repres
mean
sd
sampl
target
cell
cellswel
seed
triplic
ubottom
plate
nunc
germani
incub
peptid
h
part
prepar
splenocyt
effector
cell
e
cytokin
assay
ad
target
cell
e
ratio
target
effector
cell
cocultur
complet
rpmi
medium
supplement
heatinactiv
fb
humidifi
condit
h
incub
micropl
centrifug
min
supernat
harvest
assess
concentr
granzym
b
elisa
ebiosci
accord
manufactur
instruct
first
tumor
cell
subcutan
inocul
right
flank
mice
group
week
inocul
mice
subcutan
inject
right
footpad
peptid
regimen
pb
control
two
booster
dose
inject
week
first
inject
interv
tumor
growth
monitor
twice
week
inspect
palpat
two
month
differ
control
test
group
assess
use
oneway
anona
graphpad
prism
graphpad
softwar
surviv
rate
percentag
tumorfre
mice
evalu
use
logrank
test
valu
p
consid
statist
signific
two
independ
experi
perform
obtain
reproduc
two
replic
use
evalu
immun
respons
experi
base
previou
studi
panahi
et
al
two
differ
peptid
construct
design
fig
accord
bioinformat
predict
epitop
highest
degre
immunogen
bind
affin
mhc
molecul
popul
coverag
herein
protparam
predictprotein
scratch
server
evalu
physicochem
properti
construct
result
obtain
server
summar
tabl
data
show
peptid
construct
stabl
instabl
index
ii
respect
solubl
probabl
respect
highperform
liquid
chromatographi
hplc
mass
spectrometri
ms
report
synthes
peptid
shown
supplementari
puriti
peptid
respect
sinc
gener
play
key
role
control
hpv
infect
candid
peptid
analyz
ifnepitop
server
result
show
spataftvyvfcfl
qsvyvcafawllvf
tlqeivlhlepqneldpvdl
peptid
best
score
tabl
allergen
analysi
show
candid
peptid
allergen
predict
structur
design
epitop
itass
server
use
first
itass
gener
structur
conform
call
decoy
select
final
model
itass
use
spicker
program
cluster
decoy
base
pairwis
structur
similar
final
itass
report
top
five
model
correspond
five
largest
structur
cluster
assur
model
calcul
cscore
base
signific
thread
templat
align
converg
paramet
structur
assembl
simul
cscore
usual
rang
cscore
higher
valu
indic
model
higher
confid
cscore
best
model
peptid
construct
respect
figur
show
best
structur
peptid
construct
cscore
construct
best
structur
obtain
itass
server
submit
separ
server
refin
analysi
top
refin
model
enter
next
step
valid
structur
accord
result
server
refin
structur
highest
qualiti
factor
respect
select
analysi
figur
show
bestrefin
model
characterist
linear
antibodi
epitop
b
cell
epitop
predict
use
sequencebas
algorithm
mainli
base
amino
acid
properti
charg
hydrophob
nevertheless
predict
discontinu
epitop
need
inform
structur
protein
studi
select
refin
model
analyz
ellipro
server
predict
potenti
linear
discontinu
b
cell
epitop
peptid
construct
one
linear
epitop
vfiyiplfvihthasf
four
discontinu
epitop
identifi
peptid
construct
four
linear
epitop
faayssad
gqaepdrahi
epdtsnynivt
lhlepqneldp
five
discontinu
epitop
highest
epitop
predict
score
tabl
figur
indic
exampl
structur
put
b
cell
epitop
peptid
construct
level
total
igg
relat
subclass
assess
peptid
variou
group
fig
data
indic
highest
level
total
igg
observ
sera
mice
vaccin
mixtur
peptid
among
group
p
fig
moreov
peptid
could
increas
secret
total
igg
compar
peptid
p
interest
peptid
construct
could
significantli
induc
compar
product
p
fig
inde
data
indic
mixtur
high
intens
toward
respons
group
especi
group
receiv
mixtur
peptid
signific
antibodi
respons
could
detect
sera
control
group
inde
test
group
show
signific
antibodi
respons
antigen
compar
control
group
p
thu
seroreact
complet
antigenspecif
respons
mice
cytokin
result
pool
splenocyt
three
mice
group
indic
level
secret
group
vaccin
peptid
peptid
boost
regimen
significantli
higher
group
p
fig
secret
show
consider
differ
group
immun
peptid
alon
peptid
p
mice
immun
differ
modal
effect
enhanc
level
peptid
compar
control
group
p
data
indic
peptid
effect
peptid
secret
among
test
group
group
immun
peptid
show
signific
respons
pgml
peptid
compar
group
pgml
p
fig
moreov
test
group
demonstr
secret
higher
control
group
p
fig
data
also
show
ratio
higher
test
group
especi
group
receiv
peptid
mean
ratio
mean
ratio
peptid
respect
thu
could
significantli
activ
cellular
immun
respons
two
week
last
immun
granzym
b
secret
sampl
measur
elisa
data
show
group
immun
peptid
produc
significantli
higher
concentr
granzym
b
group
p
fig
moreov
group
immun
peptid
could
significantli
enhanc
granzym
b
secret
compar
group
immun
peptid
p
indic
potenc
peptid
peptid
secret
granzym
b
possibl
indic
cytotox
lymphocyt
ctl
activ
evalu
vaccin
potenc
tumor
growth
assess
group
shown
fig
tumor
growth
significantli
reduc
test
group
especi
group
receiv
peptid
compar
control
group
inde
mice
control
group
develop
tumor
growth
approxim
day
indic
fig
immun
peptid
could
protect
complet
mice
tumor
growth
tumorfre
mice
compar
peptid
peptid
also
control
group
mice
preestablish
tumor
inject
mixtur
peptid
pb
week
tumor
inocul
tumor
size
anim
surviv
monitor
day
follow
challeng
data
show
treatment
peptid
peptid
boost
regimen
effect
suppress
tumor
growth
mice
day
tumorfre
mice
supplementari
therapeut
vaccin
attract
strategi
stimul
immun
system
cancerassoci
hpv
highrisk
type
therapeut
vaccin
target
hpv
antigen
constitut
express
hpvassoci
malign
schiller
et
al
hpv
role
tumor
pathogenesi
cellular
transform
viru
replic
ideal
target
gener
therapeut
vaccin
kumar
et
al
chabeda
et
al
peptid
vaccin
safe
stabl
easi
produc
restrict
specif
major
histocompat
complex
mhc
anoth
issu
low
immunogen
peptidebas
vaccin
therefor
bioinformat
tool
use
solv
problem
design
multiepitop
vaccin
due
advantag
use
bioinformat
tool
mani
studi
use
tool
design
peptidebas
vaccin
hypervari
viru
human
immunodefici
viru
hiv
li
et
al
khairkhah
et
al
dengu
viru
chakraborti
et
al
coronaviru
oani
et
al
numer
previou
studi
appli
bioinformat
tool
epitop
predict
therapeut
vaccin
design
base
hpv
protein
kumar
et
al
found
potent
epitop
protein
mhci
base
immunogen
score
kumar
et
al
singh
et
al
studi
protein
sequenc
collect
highrisk
hpv
type
identifi
crossclad
immunodomin
region
introduc
peptid
amino
acid
use
potent
region
therapeut
vaccin
singh
et
al
tsang
et
al
analyz
protein
found
six
immunogen
epitop
well
tsang
et
al
oncogen
activ
well
known
role
still
rather
unclear
recent
studi
indic
import
role
oncoprotein
cell
transform
tumourigenesi
immun
modul
venuti
et
al
research
show
oncoprotein
express
earli
stage
carcinogenesi
could
target
immunotherapi
paolini
et
al
hand
presenc
viral
transcript
could
major
marker
activ
viral
infect
subsequ
target
immunotherapi
highli
express
oropharyng
cancer
opc
patient
taberna
et
al
gener
studi
focus
oncoprotein
abundantli
express
better
character
immunolog
furthermor
sequenc
conserv
gene
mahdavi
monk
studi
consid
protein
novel
target
protein
major
target
vaccin
design
base
previou
studi
panahi
et
al
overcom
mhc
limit
long
overlap
peptid
construct
contain
epitop
design
epitop
highest
score
import
paramet
bind
affin
peptid
mhc
mhci
process
peptidemhc
dock
popul
coverag
addit
previou
analys
use
structur
bioinformat
tool
determin
physicochem
properti
design
construct
potenti
epitop
allergen
linear
discontinu
b
cell
epitop
model
valid
structur
design
construct
subsequ
vivo
analysi
candid
peptid
construct
synthes
immunolog
respons
antitumor
effect
evalu
mice
physicochem
properti
peptid
construct
show
stabl
solubl
nonallergen
addit
peptid
construct
posit
charg
residu
peptid
construct
consist
posit
neg
charg
residu
hand
key
role
intracellular
immun
hpv
infect
day
et
al
data
show
spataftvyvfcflla
tlqeivlhlepqneldpvdl
highest
score
stimul
ifngamma
hpv
case
model
peptid
construct
itass
server
select
predict
protein
structur
accuraci
select
model
evalu
cscore
signific
thread
templat
align
converg
paramet
structur
assembl
simul
cscore
best
model
peptid
respect
data
show
accuraci
greater
base
ramachandran
plot
errat
score
refin
model
qualiti
predict
construct
improv
refin
fig
lead
higher
qualiti
final
model
final
model
select
input
bcell
linear
discontinu
epitop
predict
current
studi
ellipro
server
analyz
model
found
one
linear
epitop
vfiyiplfvihthasf
four
discontinu
epitop
peptid
construct
four
linear
epitop
faayssad
gqaepdrahi
epdtsnynivt
lhlepqneldp
five
discontinu
epitop
peptid
construct
data
indic
abil
design
construct
induct
bcell
respons
addit
previou
bioinformat
analysi
contain
molecular
dock
sequencebas
approach
show
epitop
high
potenc
induc
ctl
helper
cell
respons
epitop
repres
high
popul
coverag
among
differ
area
world
bioinformat
analysi
immunolog
assay
design
construct
studi
mice
inde
compar
potenc
peptid
individu
polytop
peptid
polytop
peptid
combin
regimen
polytop
peptid
plu
polytop
peptid
candid
antigen
design
bioinformat
analys
enhanc
peptid
immun
montanid
use
commerci
adjuv
result
show
peptidespecif
immun
mice
receiv
peptid
result
highest
level
secret
among
group
studi
indic
recombin
lipid
induc
high
level
immun
respons
protect
immun
mice
huang
et
al
regard
observ
protect
therapeut
studi
regimen
peptid
could
complet
confer
protect
tumor
cellchalleng
mice
depend
stimul
celldomin
respons
well
granzym
b
secret
experiment
studi
demonstr
immunogen
differ
identifi
antigen
peptid
protein
instanc
studi
show
intranas
administr
combin
peptid
vaccin
peptid
qaepdrahynivtfcckcd
peptid
rahvynivtif
peptid
qllrrevydfafrdl
peptid
vydfafrdlc
antibodi
produc
effici
therapeut
effect
high
safeti
oral
implant
meer
tumor
dortaestremera
et
al
moreov
use
cpg
motif
adjuv
peptidebas
immunotherapi
ctl
epitop
rahynivtf
led
reduc
tumor
growth
gendron
et
al
studi
show
conjug
long
peptid
gqaepdrahynivtfcckcdstlrlcvqsthvdir
ultrasmal
polymer
nanoparticl
could
enhanc
antitumor
effect
differ
mous
model
hpv
cancer
galliverti
et
al
van
der
burg
et
al
report
immunogen
epitop
includ
ctl
epitop
qaepdrahi
van
der
burg
et
al
jabbar
et
al
predict
epitop
involv
report
epitop
gqaepdrahynivtf
well
current
mani
report
indic
long
epitop
contain
longer
could
induc
effect
immun
respons
compar
short
epitop
jabbar
et
al
accord
experiment
report
design
two
vaccin
construct
longer
peptid
epitop
amino
acid
length
hpv
therapeut
vaccin
focus
hpv
oncogen
howev
vaccin
could
complet
erad
lesion
recent
hpv
oncogen
attract
special
attent
liao
et
al
show
inject
peptid
along
cpg
motif
induc
effect
cellular
immun
respons
prolong
surviv
time
tumor
cell
inocul
studi
demonstr
import
possibl
target
develop
therapeut
strategi
cervic
cancer
liao
et
al
studi
show
mixtur
immunodomin
epitop
four
type
high
risk
hpv
could
gener
high
level
indic
induct
immun
respons
well
high
granzym
b
secret
indic
ctl
activ
compar
group
receiv
peptid
individu
inde
mixtur
peptid
could
elicit
higher
immun
respons
stronger
antitumor
effect
peptid
peptid
peptid
gener
result
bioinformat
tool
show
higher
level
secret
b
cell
epitop
predict
score
peptid
versu
peptid
tabl
line
vivo
experi
confirm
bioinformat
data
show
higher
level
secret
total
igg
peptid
fig
addit
bioinformat
tool
predict
high
solubl
molecular
weight
peptid
confirm
vitro
analysi
supplementari
howev
note
vivo
experiment
data
indic
higher
capac
peptid
trigger
immun
system
combin
form
ie
inde
bioinformat
predict
pointer
potenti
immunogen
peptid
criterion
function
assign
therefor
bioinformat
analysi
confirm
experiment
approach
conclus
use
structur
sequencebas
bioinformat
tool
predict
effici
epitop
develop
therapeut
vaccin
four
preval
highrisk
hpv
type
world
vivo
result
support
immunogen
potenti
predict
peptid
especi
combin
form
ie
mixtur
peptid
herein
peptid
could
increas
immun
respons
nonspecif
enhanc
potenc
tumor
growth
howev
limit
recent
studi
lack
tumor
cell
line
express
oncoprotein
develop
tumor
cell
line
express
consid
import
approach
next
studi
moreov
suitabl
use
design
peptid
differ
modal
heterolog
primeboost
strategi
well
use
deliveri
system
improv
therapeut
vaccin
near
futur
